🔬 pathology

TSPO PET binding in vivo reflects increased phagocytic microglia at post mortem in people with frontotemporal dementia

This study demonstrates that elevated TSPO PET binding in frontotemporal dementia patients specifically reflects an increased burden of phagocytic CD68+ microglia rather than per-cell upregulation or other cell types, validating TSPO PET as a reliable biomarker for microglial activation in both FTLD-tau and FTLD-TDP pathologies.

Original authors: Vontobel, D. S., Lai, K. O., Bacioglu, M., Nolan, G., Maddison, D. C., Adamski, A., Goddard, J., Shapiro, N. L., Crook, H., Fryer, T., Hong, Y., Wijesinghe, S., Aigbirhio, F., Avezov, E., Allinson, K.

Published 2026-06-24

📖 4 min read☕ Coffee break read

CC BY 4.0

Original authors: Vontobel, D. S., Lai, K. O., Bacioglu, M., Nolan, G., Maddison, D. C., Adamski, A., Goddard, J., Shapiro, N. L., Crook, H., Fryer, T., Hong, Y., Wijesinghe, S., Aigbirhio, F., Avezov, E., Allinson, K. S. J., Quaegebeur, A., O'Brien, J. T., Rowe, J. B., Spillantini, M. G., Malpetti, M.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The Big Picture: A "Smoke Detector" Mystery

Imagine the brain as a busy city. In diseases like Frontotemporal Dementia (FTD), there is a lot of "construction work" and "cleanup crews" going on because the city is falling apart. Scientists have a special camera called a PET scan that can take a picture of this activity while a person is still alive.

For years, this camera has been looking for a specific signal called TSPO. Think of TSPO as a glowing flare that lights up when there is inflammation (the "construction work"). However, there was a big mystery: Who exactly is holding the flare?

Is it the cleanup crew (microglia)? Is it the construction workers (astrocytes)? Or is it the road crews (blood vessels)? The paper argues that for a long time, everyone assumed the flare was held by anyone working in the area. This study wanted to find out exactly who is holding the flare in FTD patients.

The Detective Work: Comparing the "Live" Photo to the "Crime Scene"

To solve this, the researchers acted like detectives comparing two different types of evidence:

The Live Photo: They took PET scans of 10 people with FTD while they were alive to see where the "glowing flares" (TSPO) were brightest.
The Crime Scene: After these same people passed away, the researchers examined their actual brain tissue under a microscope. They looked for specific markers (like ID badges) to see which cells were actually present.

They compared the "live photo" of the flares with the "crime scene" evidence of different cell types.

The Main Discovery: It's the "Trash Collectors"

The study found that the glowing flare (the PET signal) isn't just a general sign of "work being done." It is specifically linked to one type of cell: the phagocytic microglia.

The Analogy:
Imagine the brain is a house that has been trashed.

Microglia are the trash collectors.
CD68 is a specific vest that only the trash collectors wear when they are actively picking up garbage (lysosomes).
TSPO is the glowing flashlight they carry.

The researchers found that in FTD patients, the "glowing flashlight" seen on the live PET scan matches perfectly with the number of trash collectors wearing the CD68 vest.

Key Findings in Simple Terms:

More Trash, More Light: The more "trash" (cellular debris) there was in the brain, the more "trash collectors" (CD68+ microglia) showed up, and the brighter the PET scan glowed.
It's Not About Brighter Flashlights: The study checked if the individual trash collectors were just carrying brighter flashlights than usual. They found they weren't. The reason the whole room looked brighter was simply that there were more trash collectors in the room, not that each one was shining a super-bright light.
The White Matter Connection: The study noticed that the "trash" was mostly piled up in the white matter (the wiring of the brain), rather than the grey matter (the processing centers). The PET scan picked up this signal mostly from these wiring areas.
Not the Other Workers: The researchers checked if the "construction workers" (astrocytes) or "road crews" (blood vessels) were holding the flares. They found that while these cells were present, their presence did not explain why the PET scan was glowing. The signal was almost entirely driven by the trash collectors.

Does It Matter What Kind of FTD You Have?

FTD comes in different "flavors" (some caused by Tau protein, some by TDP-43 protein). The researchers were worried that maybe the "trash collectors" only showed up in one flavor of the disease.

The Result: It didn't matter. Whether the patient had the Tau version or the TDP-43 version, the PET scan was still lighting up because of the same type of trash-collecting microglia. This suggests the PET scan is a reliable way to measure this specific type of brain inflammation across different types of FTD.

The Bottom Line

This study solved a long-standing puzzle. It confirmed that when doctors see a bright spot on a TSPO PET scan in a patient with Frontotemporal Dementia, they are looking at an increase in the number of active "trash-collecting" immune cells (specifically those with the CD68 marker).

It is not because the cells are acting "louder" or "brighter" individually, but because there are simply more of them doing the cleanup work. This gives scientists and doctors a clearer understanding of what that glowing signal actually means in the living brain.

Technical Summary: TSPO PET Binding in Frontotemporal Dementia Reflects Increased Phagocytic Microglia

Problem Statement
Brain inflammation is a hallmark of frontotemporal dementia (FTD), and TSPO PET imaging using ligands like [¹¹C]PK11195 is widely employed as an in vivo proxy for neuroinflammation. However, the cellular basis of the elevated TSPO signal remains controversial. It is unclear whether the signal reflects microglial activation, astrocytic pathology, vascular changes, or a combination thereof. Furthermore, previous paradigms suggesting that microglia overexpress TSPO on a per-cell basis have been challenged by recent post-mortem studies suggesting the signal may instead reflect increased cell density or specific phenotypic states. This study aims to resolve the cellular source of TSPO PET signal elevation in FTD by directly correlating in vivo PET binding with post-mortem neuropathology across heterogeneous FTD subtypes (FTLD-tau and FTLD-TDP).

Methodology
The study utilized a clinicopathological cohort of 15 individuals: 10 patients with a clinical diagnosis of FTD (comprising 5 FTLD-tau and 5 FTLD-TDP cases, including carriers of MAPT, C9orf72, and GRN mutations) and 5 age- and sex-matched controls.

In Vivo Imaging: All FTD patients underwent [¹¹C]PK11195 TSPO PET scans and structural MRI during their lifetime. Binding potential (BPND) was calculated for 17 cortical, subcortical, brainstem, and cerebellar regions.
Post-Mortem Analysis: Brains were donated to the Cambridge Brain Bank. Tissue was formalin-fixed and paraffin-embedded.
- Immunohistochemistry (IHC): CD68 immunohistochemistry was quantified across 17 regions to assess phagocytic microglial burden.
- Multiplex Immunofluorescence: Two vicinal slide sets were prepared per subject to pair TSPO with specific cell markers: Set 1 (IBA1, CD68, TSPO) and Set 2 (GFAP, CD31, TSPO).
- 3D Single-Cell Reconstruction: Confocal microscopy and Imaris software were used to reconstruct individual IBA1+ microglia and quantify intracellular TSPO and CD68 volumes.
Statistical Modeling: Linear mixed-effects models (LMEM) were employed to analyze relationships between PET binding and post-mortem markers, accounting for subject-level random effects and regional variations.

Key Results

Elevated Phagocytic Microglia in FTD: CD68 burden (area fraction) was significantly elevated in FTD patients compared to controls. This elevation was predominantly driven by white matter regions across the cortex and cerebellum, with no significant differences found in cortical grey matter.
Correlation with TSPO PET: There was a strong, positive association between in vivo TSPO PET binding (BPND) and post-mortem CD68 area fraction across all FTD patients ( $\beta = 8.40, P < 0.001$ ). This relationship held true for both FTLD-tau and FTLD-TDP subtypes, with no significant difference in slope between the two pathologies.
Cellular Specificity of TSPO Signal:
- Co-localization: While TSPO area fraction was elevated in FTD, the specific co-localization of TSPO with CD68 (phagocytic microglia) and IBA1 (microglia/macrophages) was significantly higher in FTD than controls. Co-localization with astrocytic (GFAP) and endothelial (CD31) markers did not reach statistical significance after correction.
- Driver of PET Signal: Crucially, the in vivo TSPO PET signal correlated positively only with the CD68-TSPO co-localized fraction. It showed no positive association with IBA1-TSPO, GFAP-TSPO, or CD31-TSPO fractions.
- Per-Cell Expression: Single-cell 3D reconstruction revealed no significant difference in IBA1+ cell density or the intracellular volume fraction of TSPO within IBA1+ microglia between FTD patients and controls. This suggests the elevated PET signal is not due to per-cell upregulation of TSPO.
Grey vs. White Matter Dissociation: While CD68 burden was elevated in white matter, the coupling between TSPO PET and CD68 co-localization was driven by grey matter regions.

Key Contributions

Validation of TSPO PET as a Microglial Burden Biomarker: The study provides direct evidence that elevated TSPO PET signal in FTD reflects an increased burden of lysosome-enriched, phagocytic (CD68+) microglia rather than a general increase in microglial density or per-cell TSPO upregulation.
Pathology Independence: The finding that the TSPO-CD68 relationship is consistent across both FTLD-tau and FTLD-TDP suggests that this inflammatory mechanism is a shared feature of frontotemporal lobar degeneration, regardless of the underlying proteinopathy.
Refinement of Cellular Interpretation: By demonstrating that the signal tracks CD68+ (lysosomal) content rather than total IBA1+ cell count or per-cell TSPO levels, the study refines the interpretation of TSPO PET as a marker of specific microglial activation states (phagocytosis) rather than mere cell proliferation.

Significance
The authors conclude that the elevated [¹¹C]PK11195 signal in FTD is a robust biomarker of increased phagocytic microglial burden. This finding supports the utility of TSPO PET in experimental medicine and clinical trials targeting neuroinflammation in FTD and related disorders. The study clarifies that the signal is driven by a specific lysosome-enriched microglial phenotype, distinguishing it from other cell types and suggesting that TSPO PET captures a sustained neuroinflammatory burden characteristic of neurodegeneration, distinct from acute inflammatory responses. The authors note that while the sample size is limited by the rarity of post-mortem tissue with prior PET scans, the consistency of the findings across heterogeneous pathologies strengthens the generalizability of the conclusion.

The Big Picture: A "Smoke Detector" Mystery

The Detective Work: Comparing the "Live" Photo to the "Crime Scene"

The Main Discovery: It's the "Trash Collectors"

Does It Matter What Kind of FTD You Have?

The Bottom Line

More like this